Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System-Reference-Cited by-同舟云学术

Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System

Published:2018-04-16 Issue:6 Volume:7 Page:2269-2279
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sanagawa Akimasa¹²^ORCID,Hotta Yuji²^ORCID,Kataoka Tomoya³,Maeda Yasuhiro²,Kondo Masahiro¹,Kawade Yoshihiro²,Ogawa Yoshihiro⁴,Nishikawa Ryohei⁴,Tohkin Masahiro⁴^ORCID,Kimura Kazunori¹²³^ORCID

Affiliation:

1. Department of Pharmacy; Nagoya City University Hospital; Nagoya Japan

2. Department of Hospital Pharmacy; Graduate School of Pharmaceutical Sciences; Nagoya City University; Nagoya Japan

3. Department of Clinical Pharmaceutics; Graduate School of Medical Sciences; Nagoya City University; Nagoya Japan

4. Department of Regulatory Science; Graduate School of Pharmaceutical Sciences; Nagoya City University; Nagoya Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference45 articles.

1. Epidemiology of hepatitis B in Europe and worldwide;Alter;J. Hepatol.,2003

2. The prevalence of hepatitis B virus infection in the United States in the era of vaccination;Wasley;J. Infect. Dis.,2010

3. Hepatitis B virus management to prevent reactivation after chemotherapy: a review;Hwang;Support. Care Cancer,2012

4. Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable;Lok;Ann. Intern. Med.,2012

5. Spontaneous reactivation in chronic hepatitis B: patterns and natural history;Gupta;J. Clin. Gastroenterol.,1990

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel-induced Immune Dysfunction and Activation of Transcription Factor AP-1 Facilitate Hepatitis B Virus Replication;Journal of Clinical and Translational Hepatology;2024-03-06

2. Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database;Oncology;2023

3. Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system;Expert Opinion on Drug Safety;2021-10-24

4. Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System;Andrology;2021-08-31

5. Synthesis, anticancer evaluation, CDK2 inhibition, and apoptotic activity assessment with molecular docking modeling of new class of pyrazolo[1,5-a]pyrimidines;Research on Chemical Intermediates;2021-08-29